Technology: Organoids, Small Molecules
Industry: BioEngineering, Providers
Headquarters: San Francisco, California, United States
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 12
Total Funding: 64872758
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-08-10
Last Funding Type: Series C

Visit Website
info@prellisbio.com
https://twitter.com/Prellisbio
Register and Claim Ownership